| Issue Date | Title | Author(s) |
| 2009 | Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from mycobacterium tuberculosis | Smith, SG; Joosten, SA; Verscheure, V; Pathan, AA; McShane, H; Ottenhoff, THM; Dockrell, HM; Mascart, F |
| 2009 | Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: Comparison with boosting with a new TB vaccine, MVA85A | Whelan, KT; Pathan, AA; Sander, CR; Fletcher, HA; Poulton, I; Alder, NC; Hill, AVS; McShane, H |
| 2007 | Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: Different boosting intervals and implications for efficacy trials | Pathan, AA; Sander, CR; Fletcher, HA; Poulton, I; Alder, NC; Beveridge, NER; Whelan, KT; Hill, AVS; McShane, H |
| 2012 | A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity | Rowland, R; Brittain, N; Poulton, ID; Minassian, AM; Sander, C; Porter, DW; Satti, I; Pathan, AA; Lawrie, AM; McShane, H; Williams, N |
| 2017 | Predicting IFN-γ responses after BCG vaccination in humans from macaques: A proof-of-concept study of Immunostimulation/Immunodynamic modelling methods | Rhodes, SJ; Sarfas, C; Knight, GM; White, A; Pathan, AA; McShane, H; Evans, TG; Fletcher, H; Sharpe, S; White, RG |
| 2013 | Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A | Matsumiya, M; Stylianou, E; Griffiths, K; Lang, Z; Meyer, J; Harris, SA; Rowland, R; Minassian, AM; Pathan, AA; Fletcher, H; McShane, H |
| 27-Sep-2018 | Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection | O’Shea, MK; Tanner, R; Müller, J; Harris, SA; Wright, D; Stockdale, L; Stylianou, E; Satti, I; Smith, SG; Dunbar, J; Fletcher, TE; Dedicoat, M; Cunningham, AF; McShane, H |
| 4-Sep-2018 | Cross-laboratory evaluation of multiplex bead assays including independent common reference standards for immunological monitoring of observational and interventional human studies | Van Meijgaarden, KE; Khatri, B; Smith, SG; Drittij, AMFH; De Paus, RA; Goeman, JJ; Ho, MM; Dockrell, HM; McShane, H; Joosten, SA; Ottenhoff, THM |
| 2017 | Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials | Smith, SG; Harris, SA; Satti, I; Bryan, D; Walker, KB; Dockrell, HM; McShane, H; Ho, MM |
| 14-Dec-2018 | Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection | O'Shea, MK; Fletcher, TE; Muller, J; Tanner, R; Matsumiya, M; Bailey, JW; Jones, J; Smith, SG; Koh, G; Horsnell, WG; Beeching, NJ; Dunbar, J; Wilson, D; Cunningham, AF; McShane, H |
